JAM
EGRX
JW Asset Management’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-425,755
| Closed | -$21.5M | – | 17 |
|
|
2019
Q1 | $21.5M | Hold |
425,755
| – | – | 11.04% | 3 |
|
|
2018
Q4 | $17.2M | Sell |
425,755
-50,000
| -11% | -$2.01M | 12.64% | 3 |
|
|
2018
Q3 | $33M | Hold |
475,755
| – | – | 17.8% | 3 |
|
|
2018
Q2 | $36M | Hold |
475,755
| – | – | 22.95% | 2 |
|
|
2018
Q1 | $25.1M | Hold |
475,755
| – | – | 24.71% | 2 |
|
|
2017
Q4 | $25.4M | Sell |
475,755
-50,000
| -10% | -$2.67M | 27.04% | 1 |
|
|
2017
Q3 | $31.4M | Hold |
525,755
| – | – | 22.97% | 1 |
|
|
2017
Q2 | $41.5M | Hold |
525,755
| – | – | 26.41% | 1 |
|
|
2017
Q1 | $43.6M | Hold |
525,755
| – | – | 9.08% | 1 |
|
|
2016
Q4 | $41.7M | Hold |
525,755
| – | – | 27.76% | 1 |
|
|
2016
Q3 | $36.8M | Buy |
525,755
+276
| +0.1% | +$19.3K | 25.34% | 1 |
|
|
2016
Q2 | $20.4M | Sell |
525,479
-234,900
| -31% | -$9.11M | 16.2% | 1 |
|
|
2016
Q1 | $30.8M | Sell |
760,379
-97,300
| -11% | -$3.94M | 20.11% | 1 |
|
|
2015
Q4 | $76.1M | Buy |
857,679
+8,970
| +1% | +$795K | 28.38% | 1 |
|
|
2015
Q3 | $62.8M | Buy |
848,709
+31,825
| +4% | +$2.36M | 22.76% | 1 |
|
|
2015
Q2 | $66.1M | Buy |
816,884
+81,342
| +11% | +$6.58M | 20.08% | 1 |
|
|
2015
Q1 | $30.8M | Buy |
735,542
+633,719
| +622% | +$26.5M | 13.32% | 1 |
|
|
2014
Q4 | $1.58M | Buy |
+101,823
| New | +$1.58M | 1.18% | 19 |
|